Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $487,470 | 4 | 52.7% |
| Royalty or License | $435,727 | 4 | 47.1% |
| Consulting Fee | $1,125 | 2 | 0.1% |
| Food and Beverage | $218.18 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Arbor Pharmaceuticals, Inc. | $923,228 | 9 | $0 (2018) |
| CHF Solutions, Inc | $625.00 | 1 | $0 (2018) |
| Medicure Pharma Inc. | $615.02 | 2 | $0 (2019) |
| Akcea Therapeutics, Inc. | $36.04 | 1 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $35.79 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $35.79 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($35.79) |
| 2020 | $36.04 | 1 | Akcea Therapeutics, Inc. ($36.04) |
| 2019 | $615.02 | 2 | Medicure Pharma Inc. ($615.02) |
| 2018 | $436,352 | 5 | Arbor Pharmaceuticals, Inc. ($435,727) |
| 2017 | $487,501 | 5 | Arbor Pharmaceuticals, Inc. ($487,501) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $35.79 | General |
| Category: Cardio-renal | ||||||
| 02/08/2020 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Food and Beverage | In-kind items and services | $36.04 | General |
| Category: NEUROLOGY | ||||||
| 09/26/2019 | Medicure Pharma Inc. | ReDS (Device) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Heart Failure Device | ||||||
| 09/14/2019 | Medicure Pharma Inc. | ReDS (Device) | Food and Beverage | In-kind items and services | $115.02 | General |
| Category: Heart Failure Device | ||||||
| 10/23/2018 | Arbor Pharmaceuticals, Inc. | BiDil (Drug) | Royalty or License | Cash or cash equivalent | $156,692.65 | General |
| Category: Cardiovascular | ||||||
| 10/22/2018 | Arbor Pharmaceuticals, Inc. | BiDil (Drug) | Royalty or License | Cash or cash equivalent | $142,393.26 | General |
| Category: Cardiovascular | ||||||
| 04/30/2018 | Arbor Pharmaceuticals, Inc. | BiDil (Drug) | Royalty or License | Cash or cash equivalent | $59,970.74 | General |
| Category: Cardiovascular | ||||||
| 03/14/2018 | CHF Solutions, Inc | Aquadex (Device) | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: Cardiology | ||||||
| 02/06/2018 | Arbor Pharmaceuticals, Inc. | BiDil (Drug) | Royalty or License | Cash or cash equivalent | $76,670.04 | General |
| Category: Cardiovascular | ||||||
| 10/26/2017 | Arbor Pharmaceuticals, Inc. | Bidil (Drug) | Current or prospective ownership or investment interest | Cash or cash equivalent | $201,765.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2017 | Arbor Pharmaceuticals, Inc. | Bidil (Drug) | Current or prospective ownership or investment interest | Cash or cash equivalent | $82,667.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2017 | Arbor Pharmaceuticals, Inc. | Bidil (Drug) | Current or prospective ownership or investment interest | Cash or cash equivalent | $84,019.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/03/2017 | Arbor Pharmaceuticals, Inc. | Bidil (Drug) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/31/2017 | Arbor Pharmaceuticals, Inc. | Bidil (Drug) | Current or prospective ownership or investment interest | Cash or cash equivalent | $119,016.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
About Dr. Jay Cohn, M.D
Dr. Jay Cohn, M.D is a Internal Medicine healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598792095.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Cohn, M.D has received a total of $924,540 in payments from pharmaceutical and medical device companies, with $35.79 received in 2022. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($487,470).
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Minneapolis, MN
- Active Since 06/28/2006
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598792095
Products in Payments
- Bidil (Drug) $487,501
- BiDil (Drug) $435,727
- Aquadex (Device) $625.00
- ReDS (Device) $615.02
- TEGSEDI (Drug) $36.04
- Kerendia (Drug) $35.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Minneapolis
Dr. Nedaa Skeik, Md, MD
Internal Medicine — Payments: $669,804
Mark Reding, Md, MD
Internal Medicine — Payments: $607,358
Wesley Pedersen, Md, MD
Internal Medicine — Payments: $595,626
Shilpa Gupta, Md, Mbbs, MD, MBBS
Internal Medicine — Payments: $528,257
Dr. Marshall Hertz, M.d, M.D
Internal Medicine — Payments: $398,078
Dr. David Ingbar, M.d, M.D
Internal Medicine — Payments: $218,426